Evidence map›Paper›PMID 34876845›Full record

ArticleInternational journal of general medicine2021

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of

Tong Lin, E Zhang, Zhimei Lin, Lisheng Peng

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tong LinThe Fourth Clinical Medical School, Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.ORCID 0000-0002-0188-8166
E ZhangThe Fourth Clinical Medical School, Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Zhimei LinThe Fourth Clinical Medical School, Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Lisheng PengDepartment of Science and Education, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, People's Republic of China.ORCID 0000-0002-5530-1738
Guangzhou University of Chinese Medicine · CNShenzhen Pingle Orthopedic Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognosis of patients with advanced hepatocellular carcinoma (HCC) remains poor. Lipid remodeling modulators are considered promising therapeutic targets of cancers, owing to their functions of facilitating cancer cells' adaption to the limited environment. Lysophosphatidylcholine acyltransferases (LPCATs) are enzymes regulating bio-membrane remodeling, whose roles in HCC have not been fully illuminated.

methodsMultiple bioinformatic tools were applied to comprehensively evaluate the expression, genetic alterations, clinical relevance, prognostic values, DNA methylation, biological functions, and correlations with immune infiltration of LPCATs in HCC.

resultsWe found

conclusionThis study addressed LPCAT1/4 were potential prognostic and immunotherapeutic biomarkers of HCC targeting bio-membrane lipid remodeling.

Indexed as

bioinformaticsbiomarkerhepatocellular carcinomaimmune infiltrationLPCATs

Identifiers

PMID34876845
PMCPMC8643204
OpenAlexW3216362800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.